These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2040194)

  • 1. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.
    Obladen M; Maier R; Segerer H; Grauel EL; Holland BM; Stewart G; Jorch G; Rabe H; Linderkamp O; Hoffmann HG
    Contrib Nephrol; 1991; 88():314-26. PubMed ID: 2040194
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
    Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
    Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin therapy for anemia of prematurity.
    Gallagher PG; Ehrenkranz RA
    Clin Perinatol; 1993 Mar; 20(1):169-91. PubMed ID: 8458164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevention of anemia in premature infants: the role of recombinant human erythropoietin in a level III neonatology department].
    Klosowski S; Kongolo G; Morisot C; Thelliez P; Djebara A; Deroubaix P
    Arch Pediatr; 1999 May; 6(5):592-4. PubMed ID: 10370824
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin to prevent and treat the anemia of prematurity.
    Ohls RK
    Curr Opin Pediatr; 1999 Apr; 11(2):108-14. PubMed ID: 10202619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and neonatal anemia.
    Strauss RG
    N Engl J Med; 1994 Apr; 330(17):1227-8. PubMed ID: 8139633
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis during rapid growth. Role of erythropoietin and nutrition.
    Bechensteen AG; Halvorsen S; Hågå P
    Ann N Y Acad Sci; 1994 Apr; 718():339-40. PubMed ID: 8185241
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
    Dallman PR
    Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
    [No Abstract]   [Full Text] [Related]  

  • 11. Late-onset blueberry muffin lesions following recombinant erythropoietin administration in a premature infant.
    Pandey V; Dummula K; Fraga G; Parimi P
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):534-5. PubMed ID: 23007340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis and the approach to anemia in premature infants.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):97-9. PubMed ID: 23025780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
    Phibbs RH; Shannon KM; Mentzer WC
    Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ; Coles HJ; Stern CM; Pearson TC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of high dose therapy of rhEPO, given two or three times a week in premature infants.
    Bock W; Gröhs B; Minihold B; Schemper M; Lischka A
    J Perinat Med; 1995; 23(1-2):133-8. PubMed ID: 7658314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in anemia of prematurity.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):80-4. PubMed ID: 23025776
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 19. The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.
    Robles NR
    Clin Drug Investig; 2016 Jun; 36(6):421-31. PubMed ID: 26894799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.